about
Immune disorders in hemodialysis patientsNumerical status of CD4(+)CD25(+)FoxP3(+) and CD8(+)CD28(-) regulatory T cells in multiple sclerosisRegulatory T cells as a therapeutic tool to induce solid-organ transplant tolerance: current clinical experiences.Serological and molecular survey of toxoplasmosis in renal transplant recipients and hemodialysis patients in Kashan and Qom regions, central Iran.Association of the serum vascular endothelial growth factor levels with benign prostate hyperplasia and prostate malignancies.Comparison of cyclosporine and sirolimus effects on serum creatinine level over five years after kidney transplantation.Association of Serum Levels of Pentraxin-3, M-ficolin, and Surfactant Protein A with the Severity of Ischemic Stroke.Effects of Submaximal Aerobic Exercise on Regulatory T Cell Markers of Male Patients Suffering from Ischemic Heart Disease.The Association between Vascular Endothelial Growth Factor-related Factors with Severity of Multiple Sclerosis.Correlation of serum levels and gene expression of tumor necrosis factor-α-induced protein-8 like-2 with Parkinson disease severityEffect of hydroxymethylglutaryl-CoA reductase inhibitors on low-density lipoprotein cholesterol, interleukin-6, and high-sensitivity C-reactive protein in end-stage renal diseaseComparison of oral folic acid and folinic acid on blood homocysteine level of patients on hemodialysisMonitoring cellular immune function of renal transplant recipients based on adenosine triphosphate (ATP) production by mitogen-induced CD4+ T helper cellsRe: association of programmed cell death 1 and programmed cell death 1 ligand gene polymorphisms with delayed graft function and acute rejection in kidney allograft recipientsYKL-40 in Asthma and its correlation with different clinical parametersDynamic changes of regulatory T cell and dendritic cell subsets in stable kidney transplant patients: a prospective analysisEvaluation of Th17 pathway in the diagnosis of autosomal dominant polycystic kidney disease
P50
Q27011337-C3FEFF73-FC67-4134-A0B1-E8AA4DA092F8Q33713942-89A4B56C-41B0-457B-AED8-63E11280E1BEQ38125528-78CC566D-1D5C-408B-AF54-AB2AD849A535Q40789718-CF0BECA1-9ADF-4A52-9FE0-8A4F14DDB904Q42159112-C3B2CCF1-C935-4B36-932D-E0417BD3D142Q44492910-525209D1-147E-4387-B94C-AA334BA88D88Q47349942-65F86981-EEE6-4016-98C9-61CFF29E5861Q50721124-280488D6-30E8-4B03-9298-EA225357E4E8Q51637059-20B157D4-BDF9-4A57-A7FF-2495358F9112Q64863530-B1790B23-B7D8-45F3-98D0-F3F1BA938981Q83050158-B54684CF-B575-4497-97A6-43CE741A9144Q83050182-935E6421-C070-405A-8844-DFB9581756C6Q91771455-B1EB0E34-045B-4F54-A1E2-5E13FCC95B02Q95377340-0A2E9FFA-C2EC-4F37-9EE3-575889B67FCBQ95569737-7B80E1F0-2A18-415F-87C3-1AB3A5298B3AQ95573651-D5C07E24-C9D6-4E9E-AAB3-E7DA21DC24A8Q95625784-5CDE9BF0-2BEF-4BA3-B11A-7E7BFE211B13
P50
description
researcher ORCID ID = 0000-0001-6334-6904
@en
wetenschapper
@nl
name
Hassan Nikoueinejad
@ast
Hassan Nikoueinejad
@en
Hassan Nikoueinejad
@es
Hassan Nikoueinejad
@nl
type
label
Hassan Nikoueinejad
@ast
Hassan Nikoueinejad
@en
Hassan Nikoueinejad
@es
Hassan Nikoueinejad
@nl
prefLabel
Hassan Nikoueinejad
@ast
Hassan Nikoueinejad
@en
Hassan Nikoueinejad
@es
Hassan Nikoueinejad
@nl
P1153
36864301600
P31
P496
0000-0001-6334-6904